Derek Stemple News Today

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10m Series A financing round led by Mercia, which will be used to scale operations and continue development of its DNA synthesis platform, gSynth™ . Click to read more...

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!